-
NEWS
BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic DrugsLearn MoreBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™...
-
NEWS
BD Board Declares DividendLearn MoreThe Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common...
-
BLOG
A Virtual Solution to a Real ProblemLeveraging VR to support overtaxed healthcare workers and improve patient outcomesLearn More